FDA Inspection
Cambrex Profarmaco Milano SrlCambrex Profarmaco Milano Srl – FDA Inspection, May 19, 2017
Record Details
This FDA Inspection record concerns Cambrex Profarmaco Milano Srl, with an inspection on May 19, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 66ac1960-e277-4a92-bdb1-667be3edb250
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1021644
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cambrex Profarmaco Milano Srl
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 11, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 1, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 7, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 6, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Cambrex Profarmaco Milano Srl
- FDA Inspection 1193220 - 2022-11-11
- FDA Inspection 1167505 - 2021-10-01
- FDA Inspection 1091698 - 2019-05-07
- FDA Inspection 973972 - 2015-11-06
- FDA Inspection 861141 - 2013-12-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.